ATE451619T1 - Pkp3-onkogen als prognostischer indikator für lungenadenokarzinom - Google Patents

Pkp3-onkogen als prognostischer indikator für lungenadenokarzinom

Info

Publication number
ATE451619T1
ATE451619T1 AT05795198T AT05795198T ATE451619T1 AT E451619 T1 ATE451619 T1 AT E451619T1 AT 05795198 T AT05795198 T AT 05795198T AT 05795198 T AT05795198 T AT 05795198T AT E451619 T1 ATE451619 T1 AT E451619T1
Authority
AT
Austria
Prior art keywords
pkp3
oncogen
lung adenocarcinoma
prognostic indicator
prognostic
Prior art date
Application number
AT05795198T
Other languages
English (en)
Inventor
Yusuke Nakamura
Yataro Daigo
Shuichi Nakatsuru
Original Assignee
Onco Therapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onco Therapy Science Inc filed Critical Onco Therapy Science Inc
Application granted granted Critical
Publication of ATE451619T1 publication Critical patent/ATE451619T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05795198T 2004-10-19 2005-10-18 Pkp3-onkogen als prognostischer indikator für lungenadenokarzinom ATE451619T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62040504P 2004-10-19 2004-10-19
PCT/JP2005/019458 WO2006043692A1 (en) 2004-10-19 2005-10-18 Pkp3 oncogene as a prognostic indicator for lung cancer

Publications (1)

Publication Number Publication Date
ATE451619T1 true ATE451619T1 (de) 2009-12-15

Family

ID=35840452

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05795198T ATE451619T1 (de) 2004-10-19 2005-10-18 Pkp3-onkogen als prognostischer indikator für lungenadenokarzinom

Country Status (6)

Country Link
US (1) US8034578B2 (de)
EP (1) EP1812796B1 (de)
JP (1) JP4908401B2 (de)
AT (1) ATE451619T1 (de)
DE (1) DE602005018250D1 (de)
WO (1) WO2006043692A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112129938B (zh) * 2019-06-25 2023-08-18 中国科学院分子细胞科学卓越创新中心 UDP-Glc在肺癌转移评估中的应用
CN116920102A (zh) * 2023-07-06 2023-10-24 华南理工大学 一种plakophilin 3桥粒蛋白及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4922400A (en) * 1999-04-30 2000-11-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Means and methods for altering the functional properties in eukaryotic cells
JP2005527180A (ja) * 2001-04-18 2005-09-15 プロテイン デザイン ラブス， インコーポレイテッド 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
JP4658936B2 (ja) * 2004-03-24 2011-03-23 オンコセラピー・サイエンス株式会社 肺癌を治療するための組成物および方法

Also Published As

Publication number Publication date
DE602005018250D1 (de) 2010-01-21
EP1812796B1 (de) 2009-12-09
WO2006043692A1 (en) 2006-04-27
US20080254452A1 (en) 2008-10-16
JP2008516583A (ja) 2008-05-22
US8034578B2 (en) 2011-10-11
JP4908401B2 (ja) 2012-04-04
EP1812796A1 (de) 2007-08-01

Similar Documents

Publication Publication Date Title
DE602004008889D1 (en) Serum macrophage migration inhibitory factor (mif) als marker für prostata krebs
EP1492440B8 (de) Neues verfahren für die diagnose und prognose von malignen erkrankungen
CA2602088C (en) Biomarkers for ovarian cancer and endometrial cancer
WO2008030845A3 (en) Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis
IN2013CN01129A (de)
WO2007095644A3 (en) Reagents and methods for cancer prognosis and pathological staging
CA2816991A1 (en) Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
DE60226271D1 (de) Verfahren zum nachweis von prostatakrebs
NZ597363A (en) Prognosis prediction for colorectal cancer
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
WO2022174234A3 (en) Biomarkers for cancer treatment
EP4083233A3 (de) Verfahren zur verwendung von genexpression zur bestimmung der prognose von prostatakrebs
WO2006119435A8 (en) Identification of cancer biomarkers and phosphorylated proteins
NZ594003A (en) Cancer biomarkers
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
WO2008094678A3 (en) A molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
WO2007035690A3 (en) Methods for diagnosing pancreatic cancer
WO2010051314A3 (en) Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
WO2009055823A3 (en) Method to predict responsiveness of breast cancer to polyaminetype chemotherapy
WO2013028807A3 (en) Renal cell carcinoma biomarkers and uses thereof
WO2013057581A3 (en) Composite biomarkers for non-invasive screening, diagnosis and prognosis of colorectal cancer
WO2015091575A3 (en) Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer
Kobayashi et al. Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties